Note: Abon Pharmaceuticals's revenues are gauged from an analysis of company filings.
Abon Pharmaceuticals's Income Statement (based on Industry Averages)
Abon Pharmaceuticals P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Abon Pharmaceuticals is developing and marketing.
Abon Pharmaceuticals doesn't have any recent trademark applications, indicating Abon Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
A Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of diabetes, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, bacterial, metabolic, endocrine, reproductive, menopausal, musculoskeletal, central nervous system, cardiovascular, cardiopulmonary, genitourinary, urological, sexual dysfunction, erectile dysfunction, oncological, hepatological, hematological, genetic, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, auto-immune, and immune system related conditions, diseases and disorders; vaccines; antifungal preparations; pharmaceutical preparations for use in dermatology; cosmeceuticals, namely, medicated skin care preparations
06/14/2011
ABON PHARMACEUTICALS Pharmaceutical preparations and substances for the treatment of damaged tissue; pharmaceutical preparations and substances for the treatment of diabetes, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, bacterial, metabolic, endocrine, reproductive, menopausal, musculoskeletal, central nervous system, cardiovascular, cardiopulmonary, genitourinary, urological, sexual dysfunction, erectile dysfunction, oncological, hepatological, hematological, genetic, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, auto-immune, and immune system related conditions, diseases and disorders; vaccines; antifungal preparations
06/14/2011
See all trademarks and details in the Full Report.
Market Share of Abon Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Abon Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Abon Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Abon Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.